Representative Harshbarger Introduces House Bill to Ban Mifepristone and Allow Lawsuits Against Manufacturers

63% of all U.S. abortions in 2023 were medication abortions — about 642,700 procedures

36 deaths associated with mifepristone reported to the FDA out of an estimated 7.5+ million users since 2000

The FDA-approved label reports serious adverse events in less than 0.5% of mifepristone users; a non-peer-reviewed industry study cited by bill sponsors claims ~11%

Medication abortion mortality rate is 0.53 per 100,000; the U.S. maternal mortality rate from childbirth is 32.9 per 100,000

S. 4066 has 3 Senate cosponsors; it would need 60 votes to overcome a filibuster — Congress has never revoked FDA approval of a specific drug by legislation